Bevacizumab is a targeted therapy drug used to treat metastatic colorectal cancer, metastatic lung cancer, brain tumour, metastatic kidney cancer, liver cancer, ovarian cancer, and cervical cancer.
Bevacizumab is a targeted therapy drug used to treat metastatic colorectal cancer, metastatic lung cancer, brain tumour, metastatic kidney cancer, liver cancer, ovarian cancer, and cervical cancer.